Phase 3 clinical trials indicate that people lost 28.3% of their body weight after 80 weeks on 12 mg of retatrutide, with 45% losing 30% or more of their weight
1) Volume loss (the deflated look) Common areas: temples, midface, under-eye hollowness, around the mouth, jawline
Treatment usually begins with a lower dose to help your body adjust comfortably
Neurology (1999) 53(9):193742
Research Applications Triple hormone receptor (GLP-1/GIP/Glucagon) research Metabolic rate and energy expenditure studies Advanced obesity and weight regulation biology Insulin sensitivity and glucose metabolism research Combination incretin pathway investigations Quality Specifications Purity: 98% (HPLC verified) Compound: Retatrutide Molecular Weight: ~4.9 kDa Form: Lyophilized powder Origin: Made in the USA Testing: Third-party tested in a US laboratory Storage: -20C, protect from light COA: Batch-specific, ISO-accredited laboratory Frequently Asked Questions Q: What makes Retatrutide unique
27 Importantly, GLP-1 action is short-lived, with a half-life of just 12 minutes in the bloodstream under normal physiological conditions, after which it is broken down by the enzyme dipeptidyl peptidase IV (DPP-4), resulting in a loss of its biological activity
